In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis
- PMID: 1699780
- DOI: 10.1016/0014-4886(90)90029-r
In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis
Abstract
In monkeys, unilateral intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a useful model of hemiparkinsonism. To evaluate MPTP-induced neurochemical changes in vivo, brain microdialysis was employed to measure extracellular levels of dopamine and its metabolites in the neostriatum of normal and hemiparkinsonian rhesus monkeys (Macaca mulatta). The microdialysis probes were implanted bilaterally into the caudate nucleus and putamen at coordinates determined from magnetic resonance imaging. Dopamine and its metabolites were depleted in the MPTP-lesioned side versus the unlesioned side in hemiparkinsonian monkeys. Tyrosine hydroxylase immunocytochemistry revealed a complete unilateral denervation in the caudate nucleus and putamen and a total loss of tyrosine hydroxylase-immunoreactive cells in the substantia nigra pars compacta in those monkeys. Baseline levels of amines in the neostriatum in normal monkeys were not significantly different from those in the normal (non-MPTP-treated) side in hemiparkinsonian monkeys. These data demonstrate that brain microdialysis is a valuable tool for measuring in vivo neurochemical changes in nonhuman primate brains.
Similar articles
-
GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.Brain Res. 1999 Jan 30;817(1-2):163-71. doi: 10.1016/s0006-8993(98)01244-x. Brain Res. 1999. PMID: 9889359
-
In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys.J Neurochem. 1996 Feb;66(2):579-88. doi: 10.1046/j.1471-4159.1996.66020579.x. J Neurochem. 1996. PMID: 8592127
-
Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys.Exp Neurol. 2000 Oct;165(2):342-6. doi: 10.1006/exnr.2000.7470. Exp Neurol. 2000. PMID: 10993693
-
Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Brain Res. 1986 Dec 10;399(2):339-45. doi: 10.1016/0006-8993(86)91525-8. Brain Res. 1986. PMID: 2435361
-
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.Front Biosci. 2003 Sep 1;8:a155-66. doi: 10.2741/1104. Front Biosci. 2003. PMID: 12957824
Cited by
-
Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: an in vivo microdialysis study.Exp Brain Res. 1994;98(1):44-52. doi: 10.1007/BF00229108. Exp Brain Res. 1994. PMID: 8013591
-
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis.J Neurosci. 2008 Sep 17;28(38):9575-84. doi: 10.1523/JNEUROSCI.3465-08.2008. J Neurosci. 2008. PMID: 18799689 Free PMC article.
-
Nonhuman primate neuroimaging and cocaine medication development.Exp Clin Psychopharmacol. 2008 Dec;16(6):446-57. doi: 10.1037/a0014196. Exp Clin Psychopharmacol. 2008. PMID: 19086766 Free PMC article. Review.
-
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI.Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11169-74. doi: 10.1073/pnas.1220512110. Epub 2013 May 30. Proc Natl Acad Sci U S A. 2013. PMID: 23723346 Free PMC article.
-
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.PLoS One. 2017 Feb 6;12(2):e0169965. doi: 10.1371/journal.pone.0169965. eCollection 2017. PLoS One. 2017. PMID: 28166239 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous